The synergistic effect of RT‐PDT and PD‐1 checkpoint blockade effectively elicits superior antitumor efficacy on bilateral tumor model and lung metastatic model of 4T1 breast cancer. This evidence concerns the gene PDCD1 and breast carcinoma.